Conclusion
Introduction
Behçet's disease (BD), first described in 1937 by Turkish dermatologist Hulusi Behçet, is a symptomatic triad consisting of recurrent oral and genital ulcers and skin lesions. BD is a chronic inflammatory disease characterized by recurrent attacks, and may involve multiple systems 1 .
Although the etiology and pathology of BD has not been fully elucidated, it is believed to be triggered by .
There is evidence of a strong association between BD and MICA (major histocompatibility complex class I-related chain A). The MICA gene is located within a 46-kb centrometric region of HLA-B, and its MICA*009 allele has been shown to increase risk of BD. Furthermore, a significant relationship between BD and MICA*006 and MIC-A6 TM alleles has been reported. It has been emphasized that MIC-A may be a candidate gene for BD 4, [17] [18] [19] .
Therefore, another gene in the region with high disequilibrium linkage with B*51 may be involved in susceptibility to BD. HLA-Cw14 and Cw15 were found significantly more often in BD patients 20, 21 .
Other studies regarding the relationship between BD and HLA in different populations have shown associations between the disease and HLA A26, HLA B*3901, HLA B52, HLA B56, Cw1, Cw14, Cw15, Cw16, HLA DR*B104, and HLA DR*B107 alleles [14] [15] [16] [17] .
In this study we performed polymerase chain reaction (PCR) at low-and high-resolution subtype HLA-B loci in order to determine the frequency of HLA-B*51 and its suballeles in Turkish BD patients and healthy controls.
Material and Method
The study was approved by the Ataturk University Faculty of Medicine Ethics Committee. 
Results
In this study, the HLA-B*51 subtypes of 40 BD patients and 54 unrelated healthy individuals were evaluated.
There was a significant difference in B*51 subtype frequencies between the patient and control groups. B*5101 was the most common B*51 subtype seen in this study; in addition, the B*5109 allele was found in one BD patient and HLA-B*5108 subgroup was found in two controls.
In summary, in this study of BD patients, the common HLA-B*5101 subtype was observed, as well as HLA-B*5109 allele in one patient (Table 1) .
Discussion
Behçet's disease is a systemic vasculitis featuring attacks as well as a long-term disease course, and its etiopathology is not completely understood 22 . The strongest genetic predisposition to BD is the HLA-B*51 antigen. The HLA-B*5101 and 5108 alleles are the most common HLA-B*51 subgroups found in BD patients 9 . It has been reported that BD patients with HLA-B*51 exhibit more severe clinical symptoms and ocular involvement.
The distribution of HLA-B*51 varies by population, with rates of HLA-B*51 positivity ranging from 62 to 98% [23] [24] [25] [26] . Studies indicate that HLA-B*51 is more common in male BD patients [23] [24] [25] [26] [27] . In the current study, all 21 of the male BD patients were positive for HLA-B*51, compared to 47.5% of the female patients.
To date, 116 subtypes of HLA-B*51 have been identified 9 . HLA-B*5101 and HLA-B*5108 are the most commonly reported suballeles 8, 9, 14, 23 and data from various populations show HLA-B*5101 frequency of 62-98% 14, 24, [28] [29] [30] . The most common subtype of the BD patients in our study was heterozygous HLA-B*5101 (92.5%), while homozygous HLA-B*5101 was identified in 2 patients (5%).
Takemoto et al. found that all of the BD patients carrying HLA-B*5101 alleles in their study had the HLA-B*5101 subtype 31 . Demirseren et al. found that the HLA-B*5101 allele was the most common subtype in their study at a frequency of 97.2% ; they detected HLA-B*5101 in 94.3% and HLA-B*5108 in 57% of their patients 23 .
A study of the Turkish and German BD population revealed that HLA-B*5107 subtype had a negative effect on BD 14, 17 . The B*5108 and *5109 subtypes have also been detected in BD patients, and their sequence analysis should be investigated and compared with that of *5101 (35). HLA-B*5108 is the second most common suballele associated with BD 14 . Its incidence in the Turkish, Japanese, German, Greek, Spanish and Italian populations ranges from 10-30% 7, 8, 10, 13, 23, 32 . However, we did not detect HLA-B*5108 in the BD patients in our study. In a study by Kera et al. employing SBT, HLA-B*5101 and HLA-B*5108 were found at rates of 52% and 17.9%, respectively 7 . Demirseren et al. reported that the HLA-B*5109 subtype may be protective against the development of papulopustular lesions 23 . One patient in our study carried the HLA-B*5109 allele.
In conclusion, the results of our study indicate that the HLA-B*51 subgroup is not a causative factor in the pathogenesis of BD. 
